Open Access

High Rab11-FIP4 expression predicts poor prognosis and exhibits tumor promotion in pancreatic cancer

  • Authors:
    • Yun He
    • Mengsi Ye
    • Lingling Zhou
    • Yunfeng Shan
    • Guangrong Lu
    • Yuhui Zhou
    • Jinwei Zhong
    • Jihang Zheng
    • Zhanxiong Xue
    • Zhenzhai Cai
  • View Affiliations

  • Published online on: December 30, 2016     https://doi.org/10.3892/ijo.2016.3828
  • Pages: 396-404
  • Copyright: © He et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Some studies have demonstrated that Rab11-family interacting proteins (Rab11-FIPs) are connected with the tumorigenesis, and they may act as tumor promoters in some cancers. The clinicopathological significance of Rab11-family interacting protein 4 (Rab11-FIP4 ) expression and its possible effects on pancreatic cancer (PC) are still undiscovered. In this study, Rab11-FIP4 protein expression level in 60 PC specimens and pair-matched non-cancerous samples were detected by immunohistochemistry analysis. The results were analysed and compared with each patients' clinical data. Rab11-FIP4 expression in PC tissues increased significantly more than that of adjacent non-cancerous tissues (P=0.0001). Overexpression of Rab11-FIP4 in the PC tissues was significantly related to tumor size (P=0.0001), histological grade (P=0.028), metastasis (P=0.001) and TNM stage (P=0.004) but not with age (P=0.832), gender (P=0.228) or tumor site (P=0.875). Kaplan-Meier survival analysis showed that overexpression of Rab11-FIP4 was significantly related to overall survival time (P=0.0036). In addition, Rab11-FIP4 in PANC-1 pancreatic cancer cells were successfully knocked-out using the CRISPR/Cas9 system. Rab11-FIP4 knockout in PANC-1 cells inhibited cell growth, invasion and metastasis, and arrested cell cycle progression, but did not alter apoptosis. Our findings suggest that overexpression of Rab11-FIP4 predicts poor clinical outcomes for pancreatic cancer and contributes to pancreatic tumor progression.
View Figures
View References

Related Articles

Journal Cover

February-2017
Volume 50 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
He Y, Ye M, Zhou L, Shan Y, Lu G, Zhou Y, Zhong J, Zheng J, Xue Z, Cai Z, Cai Z, et al: High Rab11-FIP4 expression predicts poor prognosis and exhibits tumor promotion in pancreatic cancer. Int J Oncol 50: 396-404, 2017.
APA
He, Y., Ye, M., Zhou, L., Shan, Y., Lu, G., Zhou, Y. ... Cai, Z. (2017). High Rab11-FIP4 expression predicts poor prognosis and exhibits tumor promotion in pancreatic cancer. International Journal of Oncology, 50, 396-404. https://doi.org/10.3892/ijo.2016.3828
MLA
He, Y., Ye, M., Zhou, L., Shan, Y., Lu, G., Zhou, Y., Zhong, J., Zheng, J., Xue, Z., Cai, Z."High Rab11-FIP4 expression predicts poor prognosis and exhibits tumor promotion in pancreatic cancer". International Journal of Oncology 50.2 (2017): 396-404.
Chicago
He, Y., Ye, M., Zhou, L., Shan, Y., Lu, G., Zhou, Y., Zhong, J., Zheng, J., Xue, Z., Cai, Z."High Rab11-FIP4 expression predicts poor prognosis and exhibits tumor promotion in pancreatic cancer". International Journal of Oncology 50, no. 2 (2017): 396-404. https://doi.org/10.3892/ijo.2016.3828